The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index; 17 of the 36 sources its claims cite were checked for support.
Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance
Open accessAbstract
Recent studies have suggested that alpha glycerylphosphorylcholine (A-GPC) may be an effective ergogenic aid. The present study was designed to assess the efficacy of two doses of A-GPC in comparison to placebo and caffeine for increasing countermovement jump performance, isometric strength, and psychomotor function. Forty-eight healthy, college aged males volunteered for the present study and underwent baseline assessment of countermovement jump (CMJ), isometric mid thigh pull (IMTP), upper body isometric strength test (UBIST), and psychomotor vigilance (PVT). Following this assessment participants were randomly assigned to groups consisting of 500 mg A-GPC, 250 mg A-GPC, 200 mg Caffeine or Placebo taken daily. Blood samples were collected 1 h and 2 h post initial dose to quantify serum free choline and thyroid stimulating hormone then subjects returned after 7 days of supplementation to repeat CMJ, IMTP, UBIST and PVT. No differences were noted between groups for IMTP, UBIST or PVT performance. Serum free choline was found to be elevated in the two A-GPC groups as compared to placebo (132% and 59% respectively). Serum TSH was found to be significantly depressed in the 500 mg A-GPC group compared to other treatments ( p < 0.04). Group differences were noted for maximum velocity and maximum mechanical power on the CMJ ( p < 0.05) with the 250 mg A-GPC group demonstrating the greatest improvements in result. Based upon this evidence, and previous evidence regarding A-GPC, it should be considered as an emerging ergogenic supplement.
Overview
CoChat Summary
TL;DR
In a double-blind, four-arm trial of 48 healthy college-aged males, 7 days of alpha glycerylphosphorylcholine (A-GPC) increased serum free choline and produced some countermovement-jump power/velocity effects, but did not improve upper-body isometric strength or psychomotor vigilance. The 500 mg A-GPC dose also significantly depressed thyroid-stimulating hormone versus other treatments.
Key findings
- Serum free choline was significantly elevated by A-GPC treatment (F = 14.98, p = 0.001), with the 250 mg and 500 mg A-GPC groups showing 132% and 59% higher levels, respectively, than placebo.
- Serum TSH was significantly lower in the 500 mg A-GPC group (2.29 ± 0.51 μIU/ml) than placebo (3.17 ± 1.6 μIU/ml), 250 mg A-GPC (2.97 ± 1.03 μIU/ml), and caffeine (3.08 ± 0.83 μIU/ml) (p < 0.04).
- Countermovement jump showed group differences for maximum velocity (F = 0.247, p = 0.04) and maximum mechanical power (F = 2.98, p = 0.02), with the 250 mg A-GPC group showing the greatest improvements.
- No group differences were found for UBIST (F = 0.452, p = 0.743) or PVT (p > 0.5); IMTP showed a significant treatment effect (F = 2.27, p = 0.047), but only caffeine differed from placebo (p = 0.036).
Methods
- Double-blind, four-arm study: 48 healthy college-aged males were randomized to 500 mg A-GPC, 250 mg A-GPC, 200 mg caffeine, or placebo daily for 7 days.
- Baseline and post-supplementation assessments included countermovement jump (CMJ), isometric mid-thigh pull (IMTP), upper-body isometric strength test (UBIST), and psychomotor vigilance test (PVT); blood was collected at 1 h and 2 h after the initial dose for serum free choline and TSH.
- Analyses used ANOVA, repeated-measures ANOVA, and ANCOVA with body mass as a covariate for CMJ variables; significance was set at p < 0.05.
Limitations
- The authors state the findings require further verification and note “great variations in performance amongst the groups.”
- The authors state that the healthy young adult population and selected doses may have limited detection of changes in psychomotor vigilance.
- Evident from the text: each group had only 12 participants, participants were healthy college-aged males only, supplementation lasted just 7 days, and the CMJ table omits baseline and post-supplementation values for several variables.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
12 Valid · 0 Not valid · 14 Not checked · 23 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Other studies demonstrating positive results have used doses of 600 mg [10, 11]; therefore this may be the preferred dose at the present with the data available in the literature.”
- Also stated in: § Conclusions · hedged
“however, based upon the total available literature dose of 600 mg or greater are more likely to provide performance results.”
§ Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance > Discussion
What the sources say
- Supportedcites [10] source
The Methods report a 600 mg A-GPC dose, and the Results report 14% greater peak bench-press force than placebo. The citing authors’ suggestion that this may be the preferred dose is their own inference, not a conclusion attributed to this source; this study did not compare doses. (LLM, conf=0.91)
- Supportedcites [11] source
The Methods (Treatments; page unavailable) specify 600 mg of A-GPC daily, and the Results (Treatment effects—chronic; page unavailable) report a significant improvement in lower-body isometric force versus placebo. This supports the cited point that a study using 600 mg found a positive performance result. The citing authors’ suggestion that this may be the preferred dose is their own inference. (LLM, conf=0.90)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Conclusions · hedged
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In a recent publication these subclinical levels were associated with elevated cortisol, a sign of hypothyroidism [21].”
§ Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance > Discussion
What the sources say
- Partly supportedcites [21] sourceExperimental — accuracy not yet measured
The Results report a positive TSH–cortisol association when the analysis was restricted to TSH levels ≤3.0 μIU/mL and ≤2.5 μIU/mL, but not ≤2.0 μIU/mL. The Discussion describes hypothyroidism as a possible explanation for the association, not elevated cortisol as an established sign of hypothyroidism at these levels. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“There have been other studies in the past that have demonstrated increased power [10] and isometric strength [11] with A-GPC supplementation.”
§ Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance > Discussion
What the sources say
- Partly supportedcites [10] sourceExperimental — accuracy not yet measured
Citation [11] is attached to the isometric-strength claim, not the power claim. The Methods describe bench press throws, and the Results report 14% greater peak bench press force with A-GPC than placebo. The paper does not report an isometric-strength measurement, so the claimed type of strength is unsupported. (LLM, conf=0.86)
- Supportedcites [11] source
Citation [11] is attached to the isometric-strength finding, not the power finding attributed to [10]. The Conclusions report increased lower-body isometric strength after six days of A-GPC supplementation; the upper-body trend was not statistically significant. (LLM, conf=0.93)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a group of 13 college aged men, administration of A-GPC resulted in an increase of 98.8 N during an isometric mid thigh pull assessment.”
§ Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance > Background
What the sources say
- Supportedcites [11] source
The Abstract Methods describe 13 college-aged men taking 600 mg of A-GPC per day for six days. The Results (Treatment effects—chronic) report a 98.8 N mean increase from baseline in isometric mid-thigh pull peak force in the A-GPC condition. (LLM, conf=0.94)
plainstates a causen = 13- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The majority of studies use doses of around 600 mg in an acute fashion, although the only chronic dosing human performance study [11] reported changes in force production.”
§ Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance > Background
What the sources say
- Supportedcites [11] source
The Methods describe six days of A-GPC supplementation in human participants. The Results (Treatment effects—chronic) report a significant treatment-by-time effect for isometric mid-thigh pull peak force; the upper-body force change was not statistically significant. The paper therefore supports the attributed finding that chronic dosing was associated with changes in force production. (LLM, conf=0.92)
plainstates a causen = 13- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
26 more claims · 2 with their cited sources checked
Create a free account to see all 49 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 9
- Not yet classified. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serum choline was increased, along with significantly greater maximum velocity and maximum power values during a countermovement jump.”
From Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serum choline was increased, along with significantly greater maximum velocity and maximum power values during a countermovement jump.”
From Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Previous work has indicated that supplementation with alpha-glycerylphosphorylcholine (A-GPC), a choline-containing phospholipid, can increase choline levels, and in doing so may augment cognition, physical performance, and endogenous hormone production [2,3,4].”
From Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men (2024) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Briefly, Bellar et al. [3] reported statistically significant improvements in peak force production, while Marcus et al. [5] reported greater peak power production when A-GPC was provided.”
From Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men (2024) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“These results align somewhat with previous studies examining physical performance changes in young, healthy cohorts [3,5,14].”
From Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men (2024) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance > Abstract > Results
“No differences were noted between groups for IMTP, UBIST or PVT performance.”
§ Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance > Results > Analysis of isometric measures
“A significant treatment effect was revealed via the analysis (F = 2.27, p = 0.047). Post-hoc comparison revealed that only the Caffeine treatment was significantly different than the placebo (p = 0.036).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance > Discussion
“In a recent publication these subclinical levels were associated with elevated cortisol, a sign of hypothyroidism [21].”
§ Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance > References
“Elevated thyroid stimulating hormone is associated with elevated cortisol in healthy young men and women”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance > Abstract > Results
“Group differences were noted for maximum velocity and maximum mechanical power on the CMJ (p < 0.05) with the 250 mg A-GPC group demonstrating the greatest improvements in result.”
§ Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance > Results > Analysis of countermovement jump measures
“| Maximum Velocity (m/s) | Maximum Velocity (m/s) | Maximum Velocity (m/s) | Maximum Velocity (m/s) | Maximum Velocity (m/s) | | Baseline | | | | | | Post Supplmentation | | | | | | Change | −0.12 ± 0.16 | 0.01 ± 0.13 | 0.025 ± 0.16 | 0.00 ± 0.15 |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance > Methods > Participants
“VO2 Max 33.8 ± 22.5 ml/kg*min”
§ Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance > Methods > Participants
“| VO2 Max (ml/kg*min) | 500 mg A‐GPC | 33.1 ± 6.3 | 0.51 | | VO2 Max (ml/kg*min) | 250 mg A‐GPC | 34.9 ± 6.2 | 0.51 | | VO2 Max (ml/kg*min) | 200 mg Caffeine | 36.5 ± 5.9 | 0.51 | | VO2 Max (ml/kg*min) | Placebo | 30.6 ± 4.1 | 0.51 |”
Citations
Cites
Elliott, C., Green, R. A., Howells, T. H., & Long, H. A. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92759-9 · Cited by 300
Recovery after intravenous barbiturate anesthesia.
Cj, E., Green, R., Th, H., et al. (1962) · PubMed · Cited by 288
DOPAMINE INFUSION ACUTELY INHIBITS THE TSH AND PROLACTIN RESPONSE TO TRH
Besses, G. S., Burrow, G. N., Spaulding, S. W., Donabedian, R. K., & Pechinski, T. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-5-985 · Cited by 199 · cited 1×
“Additionally, it has been shown that dopamine infusion inhibits TSH response [19, 20].”
BackgroundThe Walter Reed palm-held psychomotor vigilance test
Thorne, D. R., Johnson, D. E., Redmond, D. P., Sing, H. C., Belenky, G., & Shapiro, J. M. (2005) · Behavior Research Methods · doi:10.3758/bf03206404 · Cited by 174 · cited 3×
“8) cognitive measure in the literature [16].”
MethodInfluentialRelationships of isometric mid-thigh pull variables to weightlifting performance.
Beckham, G. K., Mizuguchi, S., Carter, C., Sato, K., Ramsey, M. R., Lamont, H., Hornsby, W. G., Haff, G., & Stone, M. (2013) · PubMed · Cited by 164
DOPAMINE IS A PHYSIOLOGICAL REGULATOR OF THYROTROPHIN (TSH) SECRETION IN NORMAL MAN
SCANLON, M. F., WEIGHTMAN, D. R., SHALE, D. J., MORA, B., HEATH, M., SNOW, M. H., LEWIS, M., & HALL, R. (1979) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1979.tb03028.x · Cited by 136 · cited 2×
“[18] demonstrated this link through administration of dopamine receptor blockade that lead to significant increases in circulating TSH hormone.”
BackgroundParnetti, L., Amenta, F., & Gallai, V. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00312-8 · Cited by 132 · cited 2×
“A large review of clinical studies on dementia or cerebrovascular disorders suggest favorable results for improved cognitive fucntion with A-GPC compared to control or placebo [9].”
BackgroundParnetti, L., Mignini, F., Tomassoni, D., Traini, E., & Amenta, F. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.043 · Cited by 122 · cited 2×
“Though A-GPC has been shown to improve cognitive function in with persons suffering from vascular dementia [8, 9] these Table 2 Changes in isometric measures post-supplementation (M ± SD)”
BackgroundLECITHIN CONSUMPTION RAISES SERUM-FREE-CHOLINE LEVELS
Wurtman, R., Growdon, J., & Hirsch, M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90067-8 · Cited by 121 · cited 1×
“Another issue that many of these studies have in common is the use of choline salts, which have been demonstrated to be less effective at increasing free choline levels as compared to molecules involved in the choline biosynthetic pathway such a Lecithin (a source of phosphotidylcholine) [5, 6].”
BackgroundHirsch, M. J., Growdon, J. H., & Wurtman, R. J. (1978) · Metabolism · doi:10.1016/0026-0495(78)90139-7 · Cited by 95
Research works printed but not linked: 1
- Beckham G, 2010, J Sports Med Phys Fitness, 35, 573
Cited by
Choline supplements: An update
Kansakar, U., Trimarco, V., Mone, P., Varzideh, F., Lombardi, A., & Santulli, G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1148166 · Cited by 103
“Randomized controlled trial 500 mg and 250 mg GPC 48 healthy college-aged males -Increased maximum velocity and maximum mechanical power (56)”
MethodTest-retest reliability of isometric mid-thigh pull maximum strength assessment: a systematic review
Grgić, J., Ščapec, B., Mikulić, P., & Pedišić, Ž. (2021) · Biology of Sport · doi:10.5114/biolsport.2022.106149 · Cited by 108
A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight
Cuthbertson, C. R., Arabzada, Z., Bankhead, A., Kyani, A., & Neamati, N. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00223 · Cited by 57
The Nutritional Supplement L-Alpha Glycerylphosphorylcholine Promotes Atherosclerosis
Wang, Z., Hazen, J. E., Jia, X., Org, E., Zhao, Y., Osborn, L. J., Nimer, N. A., Buffa, J. A., Culley, M. K., Krajcik, D., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413477 · Cited by 54
“Additionally, some evidence suggests that GPC improves physical and psychomotor performance in the context of human strength and conditioning [11,12].”
BackgroundParaxanthine Supplementation Increases Muscle Mass, Strength, and Endurance in Mice
Jäger, R., Purpura, M., Wells, S. D., Liao, K., & Godavarthi, A. (2022) · Nutrients · doi:10.3390/nu14040893 · Cited by 34
“A later study by Marcus and investigators [31] reported no changes in upper- and lower-body isometric strength in 48 healthy college-aged males who randomly supplemented with either 500 mg alpha-GPC, 250 mg alpha-GPC, 200 mg caffeine, or a placebo for 7 days.”
Background
Metadata
- Authors
- Marcus, L., Soileau, J., Judge, L. W., & Bellar, D.
- Affiliations
- University of Louisiana at Lafayette (US)
- Pennington Biomedical Research Center (US)
- Ball State University (US)
- Corresponding author
- Bellar, David
- Venue
- Journal of the International Society of Sports Nutrition
- Publisher
- Informa UK Limited
- Published
- 2017-01-03
- Volume
- 14
- Issue
- 1
- Pages
- 39-39
- ISSN
- 1550-2783 (ISSN-L)
- PMC
- PMC5629791
- OpenAlex
- W2763200776
- Semantic Scholar
- 9fef203b7131f280ea282813d403ea9b8a899a2e
- Cited by
- 36
- References
- 22
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 3 · 2023: 8 · 2022: 4 · 2021: 6 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 1
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of the International Society of Sports Nutrition (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- ChemiNutra (R4475)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Sports Performance and Training
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- ergogenic aids, caffeine, countermovement jump, isometric strength, psychomotor performance, thyroid-stimulating hormone, dose comparison
- MeSH terms
- Double-Blind Method, Glycerylphosphorylcholine, Humans, Isometric Contraction, Male, Psychomotor Performance, Reproducibility of Results, Dietary Supplements, Muscle Strength, Athletic Performance, Young Adult, Sports Nutritional Physiological Phenomena, Healthy Volunteers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance. https://app.cochat.ai/papers/10.1186/s12970-017-0196-5
- The paper
- Marcus, L., Soileau, J., Judge, L. W., & Bellar, D. (2017). Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance. Journal of the International Society of Sports Nutrition. https://doi.org/10.1186/s12970-017-0196-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
